These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29562286)

  • 21. Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access.
    Sado E; Sufa A
    BMC Pediatr; 2016 Mar; 16():40. PubMed ID: 26979737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.
    Mendis S; Fukino K; Cameron A; Laing R; Filipe A; Khatib O; Leowski J; Ewen M
    Bull World Health Organ; 2007 Apr; 85(4):279-88. PubMed ID: 17546309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of prospective pathways and impacts of COVID-19 on the accessibility, safety, quality, and affordability of essential medicines and vaccines for universal health coverage in Africa.
    Amimo F; Lambert B; Magit A; Hashizume M
    Global Health; 2021 Apr; 17(1):42. PubMed ID: 33832487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An analysis of China's national essential medicines policy.
    Guan X; Liang H; Xue Y; Shi L
    J Public Health Policy; 2011 Aug; 32(3):305-19. PubMed ID: 21614030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basic survival needs and access to medicines--coming to grips with TRIPS: conversion + calculation.
    Van Puymbroeck RV
    J Law Med Ethics; 2010; 38(3):520-49. PubMed ID: 20880239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overcoming Obstacles To Enable Access To Medicines For Noncommunicable Diseases In Poor Countries.
    Kishore SP; Kolappa K; Jarvis JD; Park PH; Belt R; Balasubramaniam T; Kiddell-Monroe R
    Health Aff (Millwood); 2015 Sep; 34(9):1569-77. PubMed ID: 26355060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of medicines pricing policies in sub-Saharan Africa: protocol for a systematic review.
    Mirzoev T; Koduah A; Cronin de Chavez A; Baatiema L; Danso-Appiah A; Ensor T; Agyepong IA; Wright JM; Kretchy IA; King N
    BMJ Open; 2021 Feb; 11(2):e044293. PubMed ID: 33622951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
    Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
    PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Access to medicines and global health: will Canada lead or flounder?
    Orbinski J
    CMAJ; 2004 Jan; 170(2):224-6. PubMed ID: 14734437
    [No Abstract]   [Full Text] [Related]  

  • 30. A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications.
    Baxi SM; Beall R; Yang J; Mackey TK
    Global Health; 2019 Sep; 15(1):57. PubMed ID: 31533850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parents' and guardians' perceptions on availability and pricing of medicines and healthcare for children in eThekwini, South Africa - a qualitative study.
    Perumal-Pillay VA; Suleman F
    BMC Health Serv Res; 2017 Jun; 17(1):417. PubMed ID: 28629443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Commentary: will generic drug stores improve access to essential medicines for the poor in India?
    Kotwani A
    J Public Health Policy; 2010 Jul; 31(2):178-84. PubMed ID: 20535100
    [No Abstract]   [Full Text] [Related]  

  • 33. Availability, prices and affordability of selected essential medicines in Jordan: a national survey.
    Alefan Q; Amairi R; Tawalbeh S
    BMC Health Serv Res; 2018 Oct; 18(1):787. PubMed ID: 30340486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strengthening access to cancer medicines for children in East Africa: policy options to enhance medicine procurement, forecasting, and regulations.
    Petricca K; Carson L; Kambugu J; Denburg A
    Glob Health Res Policy; 2024 Jul; 9(1):24. PubMed ID: 38951949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Administrative cases: an effective alternative to lawsuits in assuring access to medicines?
    Chagas VO; Provin MP; Amaral RG
    BMC Public Health; 2019 Feb; 19(1):212. PubMed ID: 30786892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Access for all to quality drugs].
    Videau JY
    Med Trop (Mars); 2002; 62(4):396-400. PubMed ID: 12534178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines?
    Srivastava D; McGuire A
    BMC Public Health; 2014 Jul; 14():767. PubMed ID: 25073407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Policies and programs to facilitate access to targeted cancer therapies in Thailand.
    Sruamsiri R; Ross-Degnan D; Lu CY; Chaiyakunapruk N; Wagner AK
    PLoS One; 2015; 10(3):e0119945. PubMed ID: 25798948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia.
    Kaiser AH; Hehman L; Forsberg BC; Simangolwa WM; Sundewall J
    PLoS One; 2019; 14(12):e0226169. PubMed ID: 31834889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Public health-oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment.
    Adekola TA
    Public Health; 2019 Aug; 173():1-4. PubMed ID: 31203136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.